These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38276679)

  • 41. Seroconversion rates following 2 doses of measles- mumps- rubella vaccination given at the ages 12 and 18 months: data for possible additional dose at older age.
    Saffar H; Mousavi SJ; Saffar H; Parsaei MR; Ghorbani GR; Saffar MJ
    BMC Immunol; 2022 Jan; 23(1):2. PubMed ID: 35034609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exploring landscape of measles vaccination coverage: A step towards measles elimination goal in India.
    Dhalaria P; Kumar P; Verma A; Priyadarshini P; Kumar Singh A; Tripathi B; Taneja G
    Vaccine; 2024 Jun; 42(17):3637-3646. PubMed ID: 38704248
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Defining drivers of under-immunization and vaccine hesitancy in refugee and migrant populations.
    Deal A; Crawshaw AF; Carter J; Knights F; Iwami M; Darwish M; Hossain R; Immordino P; Kaojaroen K; Severoni S; Hargreaves S
    J Travel Med; 2023 Sep; 30(5):. PubMed ID: 37335192
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Spatial Clustering of Vaccine Exemptions on the Risk of a Measles Outbreak.
    Gromis A; Liu KY
    Pediatrics; 2022 Jan; 149(1):. PubMed ID: 34866158
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term immunogenicity of measles, mumps and rubella-containing vaccines in healthy young children: A 10-year follow-up.
    Carryn S; Feyssaguet M; Povey M; Di Paolo E
    Vaccine; 2019 Aug; 37(36):5323-5331. PubMed ID: 31345639
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Successes and challenges for preventing measles, mumps and rubella by vaccination.
    Bankamp B; Hickman C; Icenogle JP; Rota PA
    Curr Opin Virol; 2019 Feb; 34():110-116. PubMed ID: 30852425
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Measles outbreaks in Italy: A paradigm of the re-emergence of vaccine-preventable diseases in developed countries.
    Siani A
    Prev Med; 2019 Apr; 121():99-104. PubMed ID: 30763627
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation between measles vaccine doses: implications for the maintenance of elimination.
    McKee A; Ferrari MJ; Shea K
    Epidemiol Infect; 2018 Mar; 146(4):468-475. PubMed ID: 29465027
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Measles Virus Infection and Immunity in a Suboptimal Vaccination Coverage Setting.
    Pacenti M; Maione N; Lavezzo E; Franchin E; Dal Bello F; Gottardello L; Barzon L
    Vaccines (Basel); 2019 Nov; 7(4):. PubMed ID: 31795157
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
    Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The impact of COVID-19 and catch-up strategies on routine childhood vaccine coverage trends in Latin America: A systematic literature review and database analysis.
    Castrejon MM; Leal I; de Jesus Pereira Pinto T; Guzmán-Holst A
    Hum Vaccin Immunother; 2022 Nov; 18(6):2102353. PubMed ID: 36084255
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunisation coverage and factors associated with incomplete immunisation in children under two during the COVID-19 pandemic in Sierra Leone.
    Wassenaar M; Fombah AE; Chen H; Owusu-Kyei K; Williams J; Sunders JC; Llach M; Quinto L; Sesay T; Samai M; Menéndez C; González R
    BMC Public Health; 2024 Jan; 24(1):143. PubMed ID: 38200476
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outbreak of measles in a highly vaccinated secondary school population.
    Sutcliffe PA; Rea E
    CMAJ; 1996 Nov; 155(10):1407-13. PubMed ID: 8943928
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disease Progression, Clinical Features, and Risk Factors for Pneumonia in Unvaccinated Children and Adolescents with Measles: A Re-Emerging Disease in Romania.
    Turaiche M; Grigoras ML; Bratosin F; Bogdan I; Bota AV; Cerbu B; Gurban CV; Wulandari PH; Gurumurthy S; Hemaswini K; Citu C; Marincu I
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293745
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Measles vaccine coverage among children born to Somali immigrants in Norway.
    Jenness SM; Aavitsland P; White RA; Winje BA
    BMC Public Health; 2021 Apr; 21(1):668. PubMed ID: 33827509
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MMR vaccination and disease elimination: the Finnish experience.
    Davidkin I; Kontio M; Paunio M; Peltola H
    Expert Rev Vaccines; 2010 Sep; 9(9):1045-53. PubMed ID: 20822347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7 years of age or older: A phase III, randomized study.
    Abu-Elyazeed R; Jennings W; Severance R; Noss M; Caplanusi A; Povey M; Henry O
    Hum Vaccin Immunother; 2018; 14(11):2624-2631. PubMed ID: 29902133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Description of two measles outbreaks in the Lazio Region, Italy (2006-2007). Importance of pockets of low vaccine coverage in sustaining the infection.
    Curtale F; Perrelli F; Mantovani J; Ciofi degli Atti M; Filia A; Nicoletti L; Magurano F; Borgia P; Di Lallo D
    BMC Infect Dis; 2010 Mar; 10():62. PubMed ID: 20219143
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measles still spreads in Europe: who is responsible for the failure to vaccinate?
    Carrillo-Santisteve P; Lopalco PL
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():50-6. PubMed ID: 23051058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.